Dr. Charles Hamner Leads CED Biotech Forum
Two Entrepreneurial Clinician Scientists Discuss How to Improve Drug Development
[USPRwire, Mon Mar 09 2009] The Hamner Institutes for Health Sciences (www.thehamner.org) has announced that Dr. Charles Hamner, Chair of the Board of Directors, will be the moderator for the Council for Entrepreneurial Development (CED) Biotech Forum on Monday, March 16, entitled “Translating Clinical Needs into Commercial Opportunities.” The forum, which begins at 5:30 p.m., will be held at the North Carolina Biotechnology Center in Research Triangle Park and will focus on establishing new entrepreneurial strategies to meet unmet needs for cardiovascular disease and cancer.
Dr. Kim Lyerly, Director of the Duke Comprehensive Cancer Center, and Dr. Cam Patterson, Chief of Cardiovascular Medicine at The University of North Carolina-Chapel Hill, will join Dr. Hamner as featured speakers for this program. Both physicians have been internationally recognized for their contributions to building cutting-edge scientific and clinical programs and are actively involved in starting entrepreneurial ventures.
CED’s event, in partnership with the North Carolina Biotechnology Center, will convene at the North Carolina Biotechnology Center, located in the Research Triangle Park at 15 T.W. Alexander Drive. Registration begins at 5 p.m. and the forum starts at 5:30 p.m. A networking reception will follow the program at 7 p.m. Tickets are $25 for CED member and $40 for non-members. Tickets bought on-site are $45 for non-members. For more information, contact Elizabeth Call at (919) 226-0482 ext. 130 or e-mail email@example.com.
Faculty for the Biotech Forum:
H. Kim Lyerly, M.D. George Barth Geller Professor of Cancer Research Director, Duke University Comprehensive Cancer Center
• Dr. Lyerly is an internationally recognized expert in cancer therapy and cancer immunotherapy and was appointed to the National Cancer Advisory Board by President George W. Bush in 2008.
Cam Patterson, M.D., M.B.A., F.A.C.C., F.A.H.A. Ernest and Hazel Craige Distinguished Professor of Cardiovascular Medicine Chief, Division of Cardiology Director, Carolina Cardiovascular Biology Center Associate Chair for Research, Department of Medicine, University of North Carolina at Chapel Hill
• Dr. Patterson founded the Carolina Cardiovascular Biology Center in 2000 and is the chief of the Division of Cardiology at UNC.
Charles E. Hamner, D.V.M., Ph.D., Chair of the Board of Directors at The Hamner Institutes for Health Sciences
• Dr. Hamner is widely recognized by North Carolina leaders, including Governors Jim Hunt and Beverly Perdue, as being one of the founders of the biotechnology industry in the state.
• He played a major role in establishing what is now the internationally acclaimed Biotechnology Industry Organization (BIO) as well as global initiatives such as Ireland’s initial bio/pharma strategic plan.
2008-09 Series Program Sponsors are:
• Progressive Benefit Solutions (www.probenefitsolutions.com)
• Atlantic Research Group, Inc. (www.atlanticresearchgroup.com)
To find out more information or to register for the event, visit http://www.cednc.org/btforum.
“As major pharmaceutical companies struggle to fill the gaps in their drug pipelines,” said Rick Williams, Chief Business Officer of The Hamner and a member of the Biotech Forum Steering Committee, “there are more opportunities than ever for entrepreneurs to work with clinical experts to identify new ways to address unmet medical needs. We are fortunate in North Carolina to have business-savvy clinicians like Drs. Lyerly and Patterson who can help us to leverage resources at our universities to achieve greater successes in drug development.”
About The Hamner Institutes for Health Sciences:
The Hamner Institutes for Health Sciences is a nonprofit research organization strategically located on a 56-acre campus in the heart of Research Triangle Park, North Carolina. For 35 years, scientists at The Hamner have conducted preeminent research in environmental health sciences and chemical risk assessment. Built upon an integrated systems-biology platform, The Hamner has broadened its mission to include translational research in biopharmaceutical safety, metabolic disorders, and oncology. The site also includes an Accelerator, which houses emerging companies and provides opportunities to develop collaborative research and educational programs with academia, industry, and government. The Hamner model for translational research and technology development integrates innovative science with business development while capitalizing on academic and industry partnerships. The Hamner supports the discovery of new therapeutics and formation of new companies, which leads to research-based public health policy and enhanced economic development. For more information, visit www.thehamner.org or call (919) 558-1200.
About the Council for Entrepreneurial Development:
The Council for Entrepreneurial Development (CED) is a private, nonprofit organization founded in 1984 to identify, enable and promote high-growth, high-impact companies and accelerate the region’s entrepreneurial culture. Headquartered in the Research Triangle Park, CED is the oldest and largest entrepreneurial support organization in the nation with more than 5,500 active members. CED provides know-how, networking, mentoring and capital formation resources to new and existing high-growth entrepreneurs through annual conferences, programs and web-based resources. CED has helped entrepreneurs, investors, service partners, researchers and public policy makers in diverse emerging industries and at all stages of development – from high-tech, production-based organizations to service companies, from one-person start-ups to 1000-person businesses. For more information, visit www.cednc.org.
The Hamner Institutes for Health Sciences, The Hamner, Biomedical Research, North Carolina Biotechnology Center, Nonprofit, Dr. William Greenlee, Dr. Charles Hamner, Research Triangle Park, RTP, Council For Entrepreneurial Development, CED, Biotechnology, Biotech Forum, North Carolina Biotechnology Center
MMI Associates, Inc.
(919) 233-0300 (fax)